Details of the SBP
General Information of Synthetic Binding Protein (SBP) (ID: SBP003139) | ||||||
---|---|---|---|---|---|---|
SBP Name |
Monobody BMS-986192
|
|||||
Synonyms |
Monobody BMS-986192
|
|||||
Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
Highest Status | Research | |||||
Protein Scaffold Information of This SBP | ||||||
---|---|---|---|---|---|---|
Scaffold ID | PS047 | [1] , [2] | ||||
Scaffold Name | Monobody | |||||
Scaffold Class | Non-Antibody | |||||
Fold Type | Beta-Sheets + Loops | |||||
Binding Target(s) of This SBP (BTS) |
---|
BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
---|---|---|---|---|---|---|
Programmed cell death 1 ligand 1 | Binder | Molecular imaging of PD-L1 expression | N.A. | University of Groningen | [1] , [2] | |
Clinical Trial Information of This SBP | ||||||
---|---|---|---|---|---|---|
NCT03520634 | Click to show the Detail | |||||
Indication | Melanoma | |||||
Phase | Not Applicable | |||||
Title | PD-L1 PET Imaging in Melanoma Patients | |||||
Status | Completed | |||||
Sponsor | University Medical Center Groningen | |||||
NCT03843515 | Click to show the Detail | |||||
Indication | Oral Cavity Squamous Cell Carcinoma | |||||
Phase | Phase I | |||||
Title | Safety and tolerability of neoadjuvant nivolumab for locally advanced resectable oral cancer, combined with [18F]BMS-986192 / [18F]-FDG PET imaging and immunomonitoring for response prediction | |||||
Status | Recruiting | |||||
Sponsor | VU University Medical Center | |||||
References |
---|